Published in Cardiovasc Res on July 25, 2012
Genetic association analyses highlight biological pathways underlying mitral valve prolapse. Nat Genet (2015) 0.91
Mutations in DCHS1 cause mitral valve prolapse. Nature (2015) 0.89
Mitral valve disease-morphology and mechanisms. Nat Rev Cardiol (2015) 0.84
Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation. Biochim Biophys Acta (2013) 0.82
Increased Infiltration of Extra-Cardiac Cells in Myxomatous Valve Disease. J Cardiovasc Dev Dis (2015) 0.79
Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities. J Cardiovasc Dev Dis (2015) 0.77
Genetics of valvular heart disease. Curr Cardiol Rep (2014) 0.77
MVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions. J Cardiovasc Dev Dis (2015) 0.75
Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease. Cardiovasc Res (2016) 0.75
Dynamic Heterogeneity of the Heart Valve Interstitial Cell Population in Mitral Valve Health and Disease. J Cardiovasc Dev Dis (2015) 0.75
klf2a couples mechanotransduction and zebrafish valve morphogenesis through fibronectin synthesis. Nat Commun (2016) 0.75
Effect of altered haemodynamics on the developing mitral valve in chick embryonic heart. J Mol Cell Cardiol (2017) 0.75
Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25
Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med (1997) 9.36
Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol (2001) 5.99
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem (2007) 3.53
Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation (2006) 2.41
Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci U S A (2006) 2.28
Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell (2003) 2.28
Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol (1999) 2.09
Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol (2006) 2.08
Filamins in cell signaling, transcription and organ development. Trends Cell Biol (2010) 1.99
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Heart valve structure and function in development and disease. Annu Rev Physiol (2011) 1.80
Cardiac malformations and midline skeletal defects in mice lacking filamin A. Hum Mol Genet (2006) 1.74
Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture. Exp Cell Res (2003) 1.69
Purification and properties of filamin, and actin binding protein from chicken gizzard. J Biol Chem (1976) 1.60
Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine. Circulation (1999) 1.52
Periostin regulates atrioventricular valve maturation. Dev Biol (2008) 1.49
Dynamic interactions between myocytes, fibroblasts, and extracellular matrix. Ann N Y Acad Sci (2006) 1.39
Actin filaments are required for fibripositor-mediated collagen fibril alignment in tendon. J Biol Chem (2006) 1.39
Long-term serotonin administration induces heart valve disease in rats. Circulation (2005) 1.32
Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol (2002) 1.30
Filamin A regulates cell spreading and survival via beta1 integrins. Exp Cell Res (2007) 1.20
First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. Birth Defects Res A Clin Mol Teratol (2010) 1.19
Serotonylation of vascular proteins important to contraction. PLoS One (2009) 1.14
Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet (1998) 1.07
Roles of transglutaminases in cardiac and vascular diseases. Front Biosci (2007) 1.07
Microfilament rearrangements during fibroblast-induced contraction of three-dimensional hydrated collagen gels. Cell Motil (1984) 1.05
Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann N Y Acad Sci (2010) 1.02
Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis. Dev Dyn (2010) 1.00
Atrioventricular valve development: new perspectives on an old theme. Differentiation (2012) 0.98
5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats. Exp Toxicol Pathol (2008) 0.98
Cytoprotection against mechanical forces delivered through beta 1 integrins requires induction of filamin A. J Biol Chem (2001) 0.93
Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease. J Heart Valve Dis (2009) 0.90
Influence of 5-hydroxytryptamine on aortic valve competence in vitro. J Heart Valve Dis (2001) 0.89
Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J (2011) 0.88
Developmental effects of SSRIs: lessons learned from animal studies. Int J Dev Neurosci (2007) 0.86
Fenfluramine disrupts the mitral valve interstitial cell response to serotonin. Am J Pathol (2009) 0.85
Serotonin transporter gene deficiency is associated with sudden death of newborn mice through activation of TGF-beta1 signalling. J Mol Cell Cardiol (2009) 0.83
Filamin-a-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects. J Cardiovasc Transl Res (2011) 0.83
Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease. J Vet Intern Med (2010) 0.80
Characterization of amine donor and acceptor sites for tissue type transglutaminase using a sequence from the C-terminus of human fibrillin-1 and the N-terminus of osteonectin. Biomaterials (2010) 0.80
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
The GPR54 gene as a regulator of puberty. N Engl J Med (2003) 9.54
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell (2011) 6.80
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature (2003) 5.94
Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med (2003) 5.33
De novo cardiomyocytes from within the activated adult heart after injury. Nature (2011) 5.17
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm (2009) 4.99
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care (2003) 4.50
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet (2016) 4.29
Lessons from natural molecules. Nature (2004) 3.95
Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell (2011) 3.56
Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature (2011) 3.56
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem (2007) 3.53
The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. Eur J Cancer (2012) 3.41
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science (2011) 3.07
Glycopeptide and lipoglycopeptide antibiotics. Chem Rev (2005) 3.01
Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature (2010) 2.85
Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell (2012) 2.71
Organ printing: computer-aided jet-based 3D tissue engineering. Trends Biotechnol (2003) 2.66
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. J Clin Invest (2010) 2.64
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54
Organ printing: tissue spheroids as building blocks. Biomaterials (2009) 2.43
Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation (2006) 2.41
Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation (2007) 2.38
Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet (2012) 2.34
Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways. EMBO J (2004) 2.30
Clinical aspects and prognosis of Brugada syndrome in children. Circulation (2007) 2.29
Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc Natl Acad Sci U S A (2004) 2.28
The DCX-domain tandems of doublecortin and doublecortin-like kinase. Nat Struct Biol (2003) 2.22
Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition. Circ Res (2007) 2.17
Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation (2002) 2.16
miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol (2012) 2.15
An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res (2006) 2.14
In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg (2007) 2.13
Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation (2004) 2.13
YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci U S A (2012) 2.13
Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J (2007) 2.12
Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation. Circulation (2009) 2.08
Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol (2006) 2.08
Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers (2009) 2.02
Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell (2006) 2.02
Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation: importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. J Thorac Cardiovasc Surg (2010) 2.00
Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation. Circulation (2008) 2.00
Cell and organ printing 2: fusion of cell aggregates in three-dimensional gels. Anat Rec A Discov Mol Cell Evol Biol (2003) 1.98
Epicardium-derived cells in development of annulus fibrosis and persistence of accessory pathways. Circulation (2008) 1.96
Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology (2011) 1.95
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93
Human mutations in NDE1 cause extreme microcephaly with lissencephaly [corrected]. Am J Hum Genet (2011) 1.92
Capsular management during hip arthroscopy: from femoroacetabular impingement to instability. Arthroscopy (2011) 1.91
Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev Biol (2004) 1.89
Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev Biol (2008) 1.88
Developmental expression of LC3alpha and beta: absence of fibronectin or autophagy phenotype in LC3beta knockout mice. Dev Dyn (2008) 1.88
Origin of coronary endothelial cells from epicardial mesothelium in avian embryos. Int J Dev Biol (2002) 1.87
New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation (2005) 1.87
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet (2013) 1.86
Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res (2011) 1.86
In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells. Clin Cancer Res (2011) 1.85
Efficacy of serotonin inhibition in mouse models of bone loss. J Bone Miner Res (2011) 1.84
Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. J Am Coll Cardiol (2011) 1.82
Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation (2004) 1.82
Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Invest (2014) 1.82
Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest (2004) 1.80
Speckle tracking analysis allows sensitive detection of stress cardiomyopathy in severe aneurysmal subarachnoid hemorrhage patients. Intensive Care Med (2016) 1.80
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell (2012) 1.79
Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol (2009) 1.77
BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol (2006) 1.77
Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation (2006) 1.77
Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ Res (2008) 1.76
Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc Natl Acad Sci U S A (2008) 1.72
Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn (2004) 1.72
Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J (2010) 1.71
Tinnitus, diminished sound-level tolerance, and elevated auditory activity in humans with clinically normal hearing sensitivity. J Neurophysiol (2010) 1.71
Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J Am Coll Cardiol (2008) 1.70
Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling. Circulation (2012) 1.68
Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report. J Clin Oncol (2009) 1.68
Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. J Thorac Cardiovasc Surg (2003) 1.66
Saddle-shaped mitral valve annuloplasty rings experience lower forces compared with flat rings. Circulation (2008) 1.64
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet (2009) 1.64
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J (2011) 1.63
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol (2006) 1.63
Isl1 expression at the venous pole identifies a novel role for the second heart field in cardiac development. Circ Res (2007) 1.62
Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS One (2008) 1.61
Origin and fate of cardiac mesenchyme. Dev Dyn (2008) 1.61
Determinants of maximal right ventricular function: role of septal shift. J Thorac Cardiovasc Surg (2002) 1.60
Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol (2002) 1.58
Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation. JACC Cardiovasc Imaging (2013) 1.58
ENU induced mutations causing congenital cardiovascular anomalies. Development (2004) 1.58
Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg (2007) 1.57
Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm (2008) 1.56
Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer (2005) 1.55
Three-dimensional regulation of radial glial functions by Lis1-Nde1 and dystrophin glycoprotein complexes. PLoS Biol (2011) 1.53
WT1 regulates epicardial epithelial to mesenchymal transition through β-catenin and retinoic acid signaling pathways. Dev Biol (2011) 1.53
Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res (2005) 1.52
Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J (2005) 1.52